Risk Factors of Very Severe RSV Infections in a Multicenter Cohort of Very Preterm and Extreme Preterm Babies Receiving or Not Palivizumab

INTRODUCTION: Preterm infants are at risk of lower respiratory tract infections (LRTI), including Respiratory Syncytial Virus (RSV) associated bronchiolitis, for which palivizumab prophylaxis can be proposed. Our aim was to determine risk factors of very severe RSV disease in children born before 34...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulot, Gwenaelle, Benchaib, Mehdi, Plaisant, Frank, Ploin, Dominique, Gillet, Yves, Javouhey, Etienne, Claris, Olivier, Picaud, Jean-Charles, Casalegno, Jean-Sebastien, Butin, Marine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301069/
https://www.ncbi.nlm.nih.gov/pubmed/35874569
http://dx.doi.org/10.3389/fped.2022.884120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301069/
https://www.ncbi.nlm.nih.gov/pubmed/35874569
http://dx.doi.org/10.3389/fped.2022.884120

Ejemplares similares